Delivery Order SPE2DB24D8003-SPE2DB24FJTLP
Award Date
8/29/24
Potential Completion Date
8/30/24
Potential Value
$4.5K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $4,172.38 firm fixed price delivery order is for the supply of CONCERTA ER 36 MG TABLET 100S. The contract has a performance period through November 19, 2024 and is not designated as a set-aside. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA under the ECAT Generation V Program, which allows the company to...
This federal contract award, valued at $5,353.16, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order (SPE2DB25FJTSA) under the larger Indefinite Delivery Contract (IDC) SPE2DB24D8001, valued at $999,999,999.00, which allows Dakota Drug, Inc. to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract...
This federal contract award, valued at $7,561.86, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order without a set-aside designation, with a firm fixed-price pricing type and an ultimate completion date of December 17, 2024. The contract is for the delivery of CONCERTA ER 36 MG TABLET 100S, a pharmaceutical product. Dakota Drug, Inc. is a key supplier to the DLA, holding a $999,999,999.00...
This federal contract award, identified as SPE2DX15D8001|SPE2DX24FBPXC, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $7,740.41, is for the delivery of 100 units of the pharmaceutical product CONCERTA ER 36 MG TABLET. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of October 17, 2023. Dakota Drug, Inc. is a critical vendor for the DLA's medical supply chain...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Concerta ER 54 mg tablets. The contract, valued at $3,485.12, has a firm fixed-price delivery order type and an ultimate completion date of October 17, 2024. This award is not associated with any set-aside program. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $13,879.12 firm fixed-price delivery order is for the supply of 100 units of CONCERTA ER 18 MG TABLET, a prescription medication. The contract has an ultimate completion date of March 11, 2025. Dakota Drug, Inc. is an established federal contractor, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The $5,924.06 firm fixed-price delivery order is for the supply of 4565891400 CONCERTA ER 18 MG TABLET 100S. The contract, which does not have a set-aside designation, has an ultimate completion date of September 23, 2024. Dakota Drug, Inc. also holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $10,797.75, is a firm fixed-price delivery order without a set-aside designation. It covers the supply of 4,564,879,318 units of CONCERTA ER 36 MG TABLET 100S, a prescription medication, to support the medical supply chain operations for the U.S. Armed...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4,563,197,921 units of Concerta ER 36 mg tablets. The contract, valued at $35,291.38, has an ultimate completion date of December 29, 2023. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, providing a wide range of pharmaceutical products, medical supplies, and healthcare equipment to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of CONCERTA ER 54 MG TABLET 100S, a pharmaceutical product. The contract has a firm fixed price of $6,476.13 and a performance period extending through November 29, 2023. The award is not associated with a set-aside program. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at...